Type of leukemia-Acute Myeloid Leukemia (AML) - Page 3 of 8 Posts on Medivizor
Navigation Menu

Type of leukemia-Acute Myeloid Leukemia (AML) Posts on Medivizor

The effect of uric acid levels on the outcomes of patients having an allogeneic stem cell transplant

Posted by on Nov 2, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the association of uric acid levels before a stem cell transplant and patient outcomes.  This study concluded that high uric acid levels before the transplant led to increased mortality. Some background Uric acid is a product of metabolic breakdown and is a normal component of urine. It...

Read More

The effect of uric acid levels on the outcomes of patients having an allogeneic stem cell transplant

Posted by on Nov 2, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the association of uric acid levels before a stem cell transplant and patient outcomes. This study concluded that high uric acid levels before the transplant led to increased mortality. Some background Uric acid is a product of metabolic breakdown and is a normal component of urine. It can also be a...

Read More

Stem cell transplant in patients in second complete remission with core binding factor acute myeloid leukemia.

Stem cell transplant in patients in second complete remission with core binding factor acute myeloid leukemia.

Posted by on Sep 30, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes of allogeneic transplantation in patients with core-binding factor acute myeloid leukemia in second complete remission.   This study concluded that transplant was effective in a large proportion of these patients.   Some background Core binding factor acute myeloid...

Read More

Surviving cancer – is there a greater risk of cardiovascular disease long-term?

Posted by on Sep 16, 2019 in Leukemia | 0 comments

In a nutshell This study investigated if there is a higher risk of cardiovascular disease (CVD) in cancer survivors.  They found that cancer survivors have a higher risk of CVD. Some background Improved cancer detection and treatment has increased the rates of survival. The number of cancer survivors living for more than 10 years is growing. Some...

Read More

Evaluating the TLI-ATG conditioning regimen before allogeneic stem cell transplantation in patients with lymphoma or leukemia

Evaluating the TLI-ATG conditioning regimen before allogeneic stem cell transplantation in patients with lymphoma or leukemia

Posted by on Sep 13, 2019 in Leukemia | 0 comments

In a nutshell This study evaluated the safety and effectiveness of total lymphoid irradiation and anti-thymocyte globulin (TLI-ATG) conditioning before stem cell transplantation (SCT) in patients with lymphoma or leukemia. This study concluded that this regimen was well-tolerated and effective, especially for patients who had multiple lines of prior...

Read More

Evaluating the safety and effectiveness of the Shingrix vaccine for patients with leukemia or lymphoma

Evaluating the safety and effectiveness of the Shingrix vaccine for patients with leukemia or lymphoma

Posted by on Aug 23, 2019 in Leukemia | 0 comments

In a nutshell This study evaluated the safety and effectiveness of the herpes zoster vaccine (Shingrix) in patients with blood cancer who are receiving anti-cancer therapy. This study concluded that the Shingrix vaccine was effective in these patients, with manageable side effects. Some background Shingles is caused by a virus called herpes zoster....

Read More

Looking for patients with relapsed or unresponsive acute myeloid leukemia to test a new targeted therapy drug

Looking for patients with relapsed or unresponsive acute myeloid leukemia to test a new targeted therapy drug

Posted by on Jul 23, 2019 in Leukemia | 0 comments

In a nutshell This trial is examining the effectiveness of crenolanib after salvage chemotherapy for relapsed or unresponsive acute myeloid leukemia (AML) with FLT3 activating mutations. The main outcome would be survival without complications from leukemia 3 years after the treatment has finished. The details AML is a type of blood...

Read More